Navigation Links
Bema Fentanyl Demonstrates Substantial Transmucosal Delivery In,Absolute Bioavailability Study

MORRISVILLE, N.C.--(BUSINESS WIRE)--May 7, 2007 - BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced the results of a 12 subject, crossover study comparing the absorption of fentanyl from both single and multiple BEMA(TM) Fentanyl discs, as well as oral and intravenous doses of fentanyl. The data demonstrates that the absolute bioavailability (i.e. the total amount absorbed from the delivery system) of fentanyl from the BEMA(TM) disc was more than 70%, with 50% absorbed through the buccal mucosa (the inner lining of the cheek). The study further demonstrates that equal doses administered as either a single disc or multiple discs produced identical plasma concentrations (i.e. four-200 mcg discs provided the same plasma concentrations as a single-800 mcg disc).

These findings follow the company's April 25, 2007 announcement of statistically significant results with BEMA(TM) Fentanyl in treating cancer patients with breakthrough pain in the company's Phase III efficacy clinical trial. BDSI plans to include today's study results, the efficacy trial results and other materials in its planned New Drug Application (NDA) to the FDA for BEMA(TM) Fentanyl. The NDA submission is expected during the third quarter of 2007.

BEMA(TM) Fentanyl consists of a small, dissolvable polymer disc, formulated with the opioid narcotic fentanyl, for application to the buccal membranes. Upon administration, BEMA(TM) Fentanyl is designed to deliver a rapid, reliable dose of drug across mucous membranes. BEMA(TM) Fentanyl is being developed for the treatment of "breakthrough" cancer pain (i.e. episodes of severe pain which "break through" the medication already in use to control the persistent pain).

Dr. Andrew Finn, Executive Vice President of Product Development for BDSI, stated "The results of this study confirm, and are an expansion of, the information obtained in our 2006 pharmacokinetic study which demonstr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
2. BDSI Announces Positive Key Secondary Efficacy Endpoint Results for Bema Fentanyl
3. BDSI Announces Positive Phase III Clinical Trial Results for BEMA Fentanyl
4. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
5. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
6. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
7. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
8. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
9. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
10. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:8/20/2014)... -- The National Necrotizing Fasciitis Foundation (NNFF) today announced that ... treated for a life threatening form of necrotizing fasciitis, or ... Medical Director of Inpatient Wound Care and founder of The ... Rancho Mirage, California . Dr. Gauto ... at Seton Hospital in Daly City, California ...
(Date:8/20/2014)... Ariz. , Aug. 20, 2014   ... the  Roche  Group, today announced that its VENTANA ... CE marked in the European Union for routine ... The system, consisting of VENTANA Virtuoso software coupled ... VENTANA iScan HT slide scanner, provides automated digital ...
(Date:8/20/2014)... ApolloDx™ today announced it will unveil and ... event at the company,s office in Salt ... The event, which will start at 10:00 a.m., will ... .    "We believe our mobile diagnostic ... , Co-Founder and Managing Partner of ApolloDx. In addition ...
Breaking Medicine Technology:Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3
... Ga., Nov. 16 Brookstone Pharmaceuticals, an emerging specialty pharmaceutical ... the company to Acella Pharmaceuticals, LLC. This decision has ... more accurately mirrors our commitment to "Accelerating the Health Care ... Mark Pugh, CEO states, "As we have grown over the ...
... Methodist Dallas Medical Center recently made history when it became ... kidney transplant on an HIV positive patient. The patient, a ... a life free from dialysis for the first time in ... with transplant surgeons Dr. Jose Castillo-Lugo, Dr. David Nessar, and ...
Cached Medicine Technology:Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient 2Methodist Dallas Medical Center First in Metroplex to Perform Kidney Transplant on HIV Positive Patient 3
(Date:8/21/2014)... AZ (PRWEB) August 21, 2014 Drake ... have donated $10,000 to support ovarian cancer research, according ... Cundiff, who is also the kicker for the Cleveland ... Cancer Event was matched by Colleen’s Dream Foundation and ... MD, an Assistant Professor in the Division of Gynecologic ...
(Date:8/21/2014)... 2014 InSilico Medicine, a ... addressing the challenges of a rapidly aging ... signalome-wide pathway analysis. This new method ... of gene expression data obtained using high-throughput ... the journal Frontiers in Molecular Biosciences, shows ...
(Date:8/21/2014)... Today, Fecbek.com, a leading wedding dresses manufacturer ... wedding dresses. And all these elegant, gorgeous and beautiful ... designers. , A wedding dress or wedding gown is ... ceremony. Color, style and ceremonial importance of the gown ... wedding participants. In order to satisfy every customer, Fecbek.com ...
(Date:8/20/2014)... Most people think of donating food around the ... for a variety of reasons—thus making these months some ... need, Dr. Bryne Willey of AlignLife of Springfield ... wanted to heighten awareness of the need in the ... in July food drive to collect non-perishable foods for ...
(Date:8/20/2014)... Skmen.com, the popular online supplier of men’s and women’s clothes, ... online. Along with this, the company has also launched ... fresh products are offered with great discounts and low shipping ... before August 31. , Skmen.com has more than 200 ... proportion of its clothes are selling well in the current ...
Breaking Medicine News(10 mins):Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2Health News:AlignLife Springfield Office Donates 565 Canned Goods to Springfield Food Pantry 2Health News:Skmen.com: New Designs Of Mini Party Dresses Provided Online 2
... cancer will be the single leading cause of death ... stroke. Already cancer causes more deaths than HIV/AIDS, tuberculosis ... occur in developing countries, with more than a million ... Health Organization projections. , , Scot Remick, M.D., ...
... Speaker Nancy Pelosi spoke on the House floor this morning in ... Drug Administration (FDA) with authority to regulate tobacco products. The ... It passed the Senate yesterday and now goes to President ... remarks. , , "It,s really a ...
... 12 The following is a statement from Georges ... Health Association: , , "With today,s House passage of ... regulate tobacco products, our nation has finally turned the corner. ... to market their deadly products to our children and deceive ...
... HLS ) announced today that its board of ... share on its 6.5% Series A Convertible Perpetual Preferred Stock, ... July 1, 2009. , , About HealthSouth ... rehabilitative healthcare services. Operating in 26 states across the country ...
... association remains unclear, however, researchers say, , FRIDAY, June 12 ... the eye sometimes points outward are more likely to develop ... , About 1 percent of developmentally healthy U.S. children are ... line up and one looks away from the nose at ...
... N.Y., June 12 Misonix, Inc. (Nasdaq: ... device technology, which in Europe is used for the ... conditions, announced today that it has purchased three patents ... ProRhythm, Inc. The patents relate to HIFU transducer ...
Cached Medicine News:Health News:WVU Doctor Works to Reduce Cancer Burden in Africa 2Health News:Pelosi: Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 2Health News:Pelosi: Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 3Health News:Kids With Eye Condition at Risk for Poor Mental Health 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 3
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%....
Cancellous or trabecular bone that is crushed - particle size varies - primarily from distal femur, condyles, proximal tibia, femoral head, distal tibia and humeral head. Demineralized cancellous is ...
Demineralized Freeze-dried Bone Allograft (DFDBA) processed from cortical bone. Demineralized cortical powder is free of all soft tissue....
Dedicated ENT electromagnetic surgical navigation system. Value priced for comunity hospitals and surgical centers....
Medicine Products: